PCK2 and non-small cell lung carcinoma: Of note, previous studies demonstrated that PCK2-mediated production of phosphoenolpyruvate (PEP) from glutamine-derived oxaloacetate enables glucose-independent proliferation in non small cell lung cancer (NSCLC) cells (Vincent et al., 2015; Smolle et al., 2020).